BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15481866)

  • 21. Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates.
    Mills KL; Lynskey M; Teesson M; Ross J; Darke S
    Drug Alcohol Depend; 2005 Mar; 77(3):243-9. PubMed ID: 15734224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Mills K; Ross J; Darke S; Williamson A; Havard A
    Addiction; 2008 Jan; 103(1):80-8. PubMed ID: 17995994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology of heroin and other narcotics: brief terms of reference.
    Robins LN
    NIDA Res Monogr; 1977 Nov; 16():12-4. PubMed ID: 209330
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence of active heroin use in the United States.
    Hunt LG
    NIDA Res Monogr; 1977 Nov; 16():61-86. PubMed ID: 97559
    [No Abstract]   [Full Text] [Related]  

  • 25. The epidemiology of heroin and other narcotics: executive summary.
    NIDA Res Monogr; 1977 Nov; 16():1-6. PubMed ID: 209329
    [No Abstract]   [Full Text] [Related]  

  • 26. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Is it possible a new heroin consumption epidemic in Spain?].
    Mur Sierra A; Ortigosa Gómez S
    Med Clin (Barc); 2014 Nov; 143(9):398-400. PubMed ID: 25110182
    [No Abstract]   [Full Text] [Related]  

  • 28. Biasing factors in the measurement of trends in heroin use.
    Gould LC; Thompson WD; Berberian RM
    Addict Dis; 1977; 3(2):151-75. PubMed ID: 616183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of a reduction in drug supply on demand for and compliance with treatment for drug dependence.
    Degenhardt L; Conroy E; Day C; Gilmour S; Hall W
    Drug Alcohol Depend; 2005 Aug; 79(2):129-35. PubMed ID: 16002022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.
    Koester S; Glanz J; Barón A
    AIDS Behav; 2005 Mar; 9(1):27-39. PubMed ID: 15812611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heroin and the federal strategy: a policy in search of evidence.
    Goldman F
    J Psychoactive Drugs; 1981; 13(3):217-25. PubMed ID: 7038071
    [No Abstract]   [Full Text] [Related]  

  • 34. Business as usual: heroin distribution in the United States.
    McBride RB
    Int J Health Serv; 1984; 14(4):529-46. PubMed ID: 6500783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, associated risks, and treatment patterns of insomnia.
    Roth T
    J Clin Psychiatry; 2005; 66 Suppl 9():10-3; quiz 42-3. PubMed ID: 16336036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV infection among heroin users and area of residence.
    Long J; Keenan E; Grogan L; Mullen L; Barry J; Sinclair H
    Ir Med J; 2006 Sep; 99(8):230-3. PubMed ID: 17120604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.
    Darke S; Ross J; Williamson A; Teesson M
    Addiction; 2005 Aug; 100(8):1121-30. PubMed ID: 16042642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription naloxone: a novel approach to heroin overdose prevention.
    Sporer KA; Kral AH
    Ann Emerg Med; 2007 Feb; 49(2):172-7. PubMed ID: 17141138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.